Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Equity Income (2018 - 2025)

Sanara MedTech (SMTI) has disclosed Equity Income for 5 consecutive years, with -$288642.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Income changed N/A year-over-year to -$288642.0, compared with a TTM value of -$686291.0 through Sep 2025, changed N/A, and an annual FY2024 reading of -$90007.0, down 135.85% over the prior year.
  • Equity Income was -$288642.0 for Q3 2025 at Sanara MedTech, down from -$195482.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$58559.0 in Q4 2024 and bottomed at -$379633.0 in Q1 2022.
  • Average Equity Income over 4 years is -$186983.4, with a median of -$179769.0 recorded in 2021.
  • Peak annual rise in Equity Income hit 282.95% in 2022, while the deepest fall reached 282.95% in 2022.
  • Year by year, Equity Income stood at -$144180.0 in 2021, then crashed by 163.3% to -$379633.0 in 2022, then surged by 84.57% to -$58559.0 in 2024, then tumbled by 392.91% to -$288642.0 in 2025.
  • Business Quant data shows Equity Income for SMTI at -$288642.0 in Q3 2025, -$195482.0 in Q2 2025, and -$143608.0 in Q1 2025.